B3 lesions of the breast

Exam relevance: in 4 of more than 150 board exam reports · rank 111

Specialty
Gynaecology · Breast
Images
Ultrasound 1 · Histology & cytology 1
Exam relevance
4 of more than 150 reports · rank 111
In the app
1 flashcard · GynFuchs
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (2)
  2. Definition
  3. Classification
  4. Occurrence & epidemiology
  5. Clinical features
  6. Histology
  7. Diagnosis
  8. Treatment principles
  9. Keep learning in the app
  10. Further reading (selection)
  11. Cross-references

Images (2)

B3 lesions of the breast – Breast ultrasound: hypoechoic, ill-defined lesion with posterior acoustic shadowingUltrasound
Breast ultrasound: hypoechoic, ill-defined lesion with posterior acoustic shadowingImage: SCiardullo, “Caso 1 Ecografia 1” (Wikimedia Commons) · CC BY-SA 3.0 · Source · cropped
B3 lesions of the breast – Breast ultrasound: large, heterogeneous solid lesion — histologically a phyllodes tumourHistology & cytology
Breast ultrasound: large, heterogeneous solid lesion — histologically a phyllodes tumourImage: Cerevisae (Wikimedia Commons) · CC BY-SA 4.0 · Source · cropped
1 / 2

Definition

  • B3 lesions are breast lesions of uncertain malignant potential: a heterogeneous group with a borderline histological spectrum and a variable but low risk of associated malignancy.

Classification

B classification

  • B classification: The classification from B1 to B5 describes the assessment of malignancy potential of the core biopsy material, from normal tissue to malignancy.
  • B3 lesions: B3 lesions with uncertain malignant potential include atypical ductal hyperplasia, flat epithelial atypia, lobular neoplasia, and papilloma.
  • They include atypical ductal hyperplasia (ADH), flat epithelial atypia, classical lobular neoplasia, papillary lesions, benign phyllodes tumours and radial scars.
  • If carcinoma is found in subsequent tissue, DCIS is categorised as B5a and invasive carcinoma as B5b.

Occurrence & epidemiology

Epidemiology

  • Between 4 and 9% of all core needle biopsies are classified as B3, with numbers increasing due to MRI and vacuum-assisted biopsy; the positive predictive value for malignancy has fallen from 29 to 10%.
  • Atypical hyperplasia (ADH and atypical lobular hyperplasia) is found in 4–10% of benign breast biopsies performed for imaging findings or palpable lesions.

Clinical features

  • ADH is usually found incidentally on needle biopsy specimens obtained because of abnormal mammographic findings; flat epithelial atypia mostly appears as microcalcifications on mammography.

Histology

  • Histologically ADH essentially resembles low-grade DCIS and is distinguished by extent: below 2 mm it is diagnosed as ADH, above 2 mm as low-grade DCIS.
  • ADH increases breast cancer risk about fivefold; it is regarded as a risk lesion rather than a precursor lesion, because the associated carcinoma can arise anywhere in either breast and not only at the site of the ADH.

Diagnosis

  • The diagnosis is made on core needle biopsy (mostly 14G) or vacuum-assisted biopsy (7G–11G) under ultrasound, stereotactic or MRI guidance.
  • The rate of carcinoma in subsequent tissue varies by lesion; in the consensus conference data it was highest for ADH (27.6%) and considerably lower for papillary lesions (7.8%).

Treatment principles

  • Management is decided by an interdisciplinary team after correlating imaging and histology, ideally at the pre- and postoperative conference of a breast centre.
  • Depending on lesion type, atypia and concordance of findings, vacuum-assisted excision, open surgical excision or, for selected lesions without atypia, imaging surveillance may be appropriate.
  • Risk-adapted follow-up is arranged after treatment.

Specific treatment regimens with drugs and doses are covered in the GynFuchs app.

Keep learning in the app

In the GynFuchs app you can learn B3 lesions of the breast with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

In the app: 1 flashcard on this topic

Open in browser  About GynFuchs →

Further reading (selection)

  1. StatPearls: Atypical Ductal Hyperplasia (NCBI Bookshelf)
  2. The Complex Path from Mammary Ductal Hyperplasia to Breast Cancer: Elevated Malignancy Risk in Atypical Forms
  3. DocCheck Flexikon, Mammakarzinom

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.

Related pages: Ductal carcinoma in situ (DCIS) · Fibroadenoma · Galactorrhoea

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.